Corporate Partnership and Philanthropy Case Study Glenn H. Fredrickson Professor, Departments of Chemical Engineering & Materials Director, Mitsubishi Chemical Center for Advanced Materials (MC-CAM) Director, Complex Fluids Design Consortium (CFDC) University of California, Santa Barbara
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Corporate Partnership and Philanthropy Case Study
Glenn H. Fredrickson
Professor, Departments of Chemical Engineering & MaterialsDirector, Mitsubishi Chemical Center for Advanced Materials (MC-CAM)
Director, Complex Fluids Design Consortium (CFDC)
University of California, Santa Barbara
Agenda
Mitsubishi Chemical Center for Advanced Materials (MC-CAM)
Complex Fluids Design Consortium (CFDC)
The Mitsubishi Chemical Center for Advanced Materials
MC-CAM Annual Review 2017
4
2017.4.1
The KAITEKI Institute, Inc.
100%100% 56.3% 50.6%
Mitsubishi Chemical Holdings Corporation*1
Consolidated net sales: ¥3,823.1 billion
Employees: 68,988
Mitsubishi Chemical Holdings America
Mitsubishi Chemical Holdings Europe
㈱生命科学インスティテュート
大陽日酸㈱*
100%
Group companies Group companies Group companies グループ会社
Integrated on April 1, 2017
Taiyo Nippon Sanso
Corporation*1
【Sales】calculated from the simple sum of figures of FY2015
【Employees】as of March 31, 2016
Nov. 2010~
Apr. 2009~
Mitsubishi Chemical Holdings (Beijing) Co., Ltd. Jan. 2011~
Nov. 2012~
Mitsubishi Chemical Holdings Corporate Staff, Inc. Apr. 2013~
Holding company Function-sharing companies
Performance Products
Health Care
Industrial Materials
<Business domains>
Mitsubishi Chemical Holdings Corporation
Operating Companies
*1Listed Company
Mitsubishi Chemical
Corporation
Mitsubishi Tanabe
Pharma Corporation*1
Life Science
Institute, Inc.
Apr. 2017~
net sales:*2
¥ 2,775.1 billion
Group employees*2
41,591
[ Line of businesses ]
Performance products,
Industrial materials etc.
Oct. 2007~
Consolidated net sales:
¥ 431.7 billion
Group employees
8,125
[ Line of businesses ]
Pharmaceuticals etc.
Apr. 2014~
Consolidated net sales:
¥ 136.0 billion
Group employees
4,751
[ Line of businesses ]Health and Medical ICT,
Advanced MedicationDrug Development andManufacturing Solutions
Nov. 2014~
Consolidated net sales:
¥ 641.5 billion
Group employees
14,127
[ Line of businesses ]
Industrial gases& related equipment /
devices etc.
Group companies
Other figures are for the year ended March 31,2016
*2Mitsubishi Chemical Corporation
5
2017.4.1
Health Care
Industrial Materials
Performance Products
Pharmaceuticals
Diagnostic reagents
and instruments
Clinical testing
Neat resins and composites
Recording mediaElectronics related
products
Information materials
Inorganic chemicals
Food ingredients
Battery materials
Fine chemicals
Polymer processing materials
Composite materials
Basic petrochemicals
Chemical derivatives Synthetic fiber materials
Carbon products
Main Businesses
Chemical fibersPharmaceutical
formulation materials
Industrial gases
A Model Research Partnership
MCC taps into the broad interdisciplinary materials expertise at UCSB
UCSB researchers participate in creating new materials, devices, and processes for the specialty chemical & materials sector
Mitsubishi Chemical – Center for Advanced Materials (MC-CAM), the vehicle for the alliance
MC-CAM commenced in 2001: Gen 1 2001-2006
Gen 2 2006-2010
Gen 3 2010-2014
Gen 4 2014-2018
Gen 5 2018-2022
A 17+ year relationship!
Character of Research Projects
Project co-leaders from UCSB and MCC
MCC/Japan research partners are very involved
2 MCC employees are stationed at UCSB
Researchers from at least 2 disciplines
Scientific novelty
Clear connection with a potential product
Strategic alignment with 5-year MCC R&D strategy
Since 2001, research themes have included: Specialty polymers OPV and OTFT Battery/fuel cell materials Fullerenes/graphenes Catalysts Nanocomposites Phosphors Encapulants Quantum dots…
Si
La
N
What Constitutes Success?Our Vision in 2001
First-rate science and engineering
Quality publications
Well-trained students and post-docs
Patents
Technology or knowledge transfer to MCC
Technology utilized in existing or new businesses (MCC responsibility)
Fruits of Gen 1 and 2 Research
Organic white PLED fabricated by wet coating Worlds best luminescent intensity
Fuel Cell proton exchange membrane Meeting DOE target
III-V nano particle Highest quantum efficiency
Organic two photon absorption dye Highest TPA cross section
Functional polyolefins Novel thermoplastic elastomers from E & P Broad catalyst families for improved control over
co-monomer insertion and placement
Phosphors New important families of R,G,B,Y White LED independent of Nichia patents
Fullerene Derivatives Enhanced solubility and functionality to add value
LED encapsulants Thermal & uv stability, adhesion, and
transparency
cathode
ETL
EML
HIL
glass
ITO
HTL
OO
n m
MC-CAM Publications & Presentations
167 publications to date in prestigious journals including Advanced Materials Proc. NAS Advanced Functional Mater. J. Appl. Phys. Nanoletters J. Am. Chem. Soc. Chem. Mater. Synth. Metals Langmuir Macromolecules Angew. Chemie Phys. Rev. Lett. …
160 presentations & posters to date
Patent Activity
105 Invention Disclosures to UCSB to Date
30 Disclosures with MCC co-inventors (~30%)
Patents in Prosecution: 20 in US 29 outside US
Utility Patents Issued (97 total): 57 US Patents Issued 40 Patents Issued Outside US
Our portfolio managers:
-UCSB-TIA: Mary Raven
-Gates & Cooper: William Wood and Brendan Serapiglia
0
2
4
6
8
10
2011 2012 2013 2014 2015 2016 2017 2018
Series2 3 4 3 5 5 8 5 3
Dis
clo
sure
sFiscal Year
Research Efficiency in InnovationResearch Institution Average1
The CFDC has pioneered directed self-assembly (DSA) simulation tools that are guiding the development of robust materials and processes for next generation microelectronics patterning (lithography)
Chemo-epitaxy
Grapho-epitaxy
CFDC Consortium Model
Computational approaches, understanding, tools, and software are jointly developed at UCSB
CFDC member companies get royalty-free licenses to use the software in house for proprietary R&D and product development
CFDC
Company B
Company CCompany D
Company A Software and knowledge
Funds
Broader Objectives and Benefits
Create a world-renowned center for complex fluid and soft materials modeling
Companies share cost/risk of research and software development of mutual interest
Create employment opportunities for the students and post-docs of the consortium
Because the UCSB research is open, no IP negotiations are necessary -- sponsorship can be an unrestricted gift
Industrial Partners Mitsubishi Chemical
GE Corp. R&D
Arkema
Rhodia
Nestle
Accelerys
IBM
DSM (Strain localization in flow, reactive blending)
Intel (Directed Self-Assembly)
Dow Chemical (Directed Self-Assembly, inverse design)